Non‐biologic immunosuppressive drugs for inflammatory and autoimmune skin diseases
JDDG: Journal der Deutschen Dermatologischen Gesellschaft · 2024-03 · 22 (3) · 400-421
DOI: 10.1111/ddg.15270 ↗Kurz gefasst
Fachartikel in der Zeitschrift JDDG: Journal der Deutschen Dermatologischen Gesellschaft, online erschienen am 23.01.2024. Verfasst von Danai Dionysia Kanatoula und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Venereology and Allergology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humbol…. Hauptthemen laut MEDLINE: Skin Diseases, Autoimmune Diseases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Non‐biologic immunosuppressive drugs, such as azathioprine, dapsone or methotrexate are fundamental treatment options for a wide range of autoimmune and chronic inflammatory skin diseases. Some of these drugs were initially used for malignancies (e.g., azathioprine or methotrexate) or infectious diseases (e.g., hydroxychloroquine or dapsone) but are nowadays mostly used for their immunosuppressive/immunomodulating action. Although dermatologists have years of clinical experience with these drugs, some of the mechanisms of action are not fully understood and are the subject of research. Although these drugs are commonly used, lack of experience or knowledge regarding their safety profiles and management leads to skepticism among physicians. Here, we summarize the mechanism of action and detailed management of adverse effects of the most commonly used immunosuppressive drugs for skin diseases. Furthermore, we discuss the management of these drugs during pregnancy and breastfeeding, as well as their interaction and handling during vaccination.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Venereology and Allergology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.
- Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BIH Biomedical Innovation Academy, BIH Charité Clinician Scientist Program, Berlin, Germany.
ORCID-Profile: Farzan Solimani
Zitieren
APA
Kanatoula, D. D., Bodner, E., Ghoreschi, K., Meier, K., & Solimani, F. (2024). Non‐biologic immunosuppressive drugs for inflammatory and autoimmune skin diseases. JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 22(3), 400-421. https://doi.org/10.1111/ddg.15270
Vancouver
Kanatoula DD, Bodner E, Ghoreschi K, Meier K, Solimani F. Non‐biologic immunosuppressive drugs for inflammatory and autoimmune skin diseases. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2024;22(3):400-421. doi:10.1111/ddg.15270
BibTeX
@article{Kanatoula2024,
author = {Kanatoula, Danai Dionysia and Bodner, Euna and Ghoreschi, Kamran and Meier, Katharina and Solimani, Farzan},
title = {Non‐biologic immunosuppressive drugs for inflammatory and autoimmune skin diseases},
journal = {JDDG: Journal der Deutschen Dermatologischen Gesellschaft},
year = {2024},
volume = {22},
number = {3},
pages = {400--421},
doi = {10.1111/ddg.15270}
}
EUVIMED